Abstract
Science-based biomedical innovation is a complex process that calls on cooperative activity between a number of public and private-sector organisations and professions, such as the role of physicians and hospitals in the conduct of clinical trials. Basing itself on the literature that discusses innovation as the outcome of user-producer interaction, which has been concerned mainly with manufacturing innovations, this paper discusses the impact of end-users, ie patients, on the process of biomedical innovation. Primary evidence of the involvement of user groups in a number of current developments is discussed, and the prospects for generalising such findings is analysed.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
